New Delhi [India], February 12 (ANI/NewsVoir): Morepen Laboratories Ltd. is eyeing an all-new multi-billion dollar global API (Active Pharmaceutical Ingredients) market with the addition of new molecules in its bulk drugs portfolio. The focus areas of these new molecules include chronic and